Lorusso, P. M. External Author

Publications

Sort by

Selected publications

  • Phase i study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)British Journal of Cancer2011 Academic Article GET IT
    Times cited: 139